Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition

Tyrosine kinase inhibitors (TKIs) are now the mainstay of treatment in many types of cancer. However, their benefit is frequently short-lived, mandating the search for safe potentiation strategies. Cycles of fasting enhance the activity of chemo-radiotherapy in preclinical cancer models and dietary...

Descripción completa

Detalles Bibliográficos
Autores principales: Caffa, Irene, D'Agostino, Vito, Damonte, Patrizia, Soncini, Debora, Cea, Michele, Monacelli, Fiammetta, Odetti, Patrizio, Ballestrero, Alberto, Provenzani, Alessandro, Longo, Valter D., Nencioni, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494907/
https://www.ncbi.nlm.nih.gov/pubmed/25909220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494907/
https://www.ncbi.nlm.nih.gov/pubmed/25909220

Ejemplares similares